URIBEL TABS
RxNorm 1037234· METHENAMINE, BENZOIC ACID, PHENYL SALICYLATE, METHYLENE BLUE, AND HYOSCYAMINE SULFATE· ORAL
Nitrogen Binding Agent [EPC] · Mission Pharmacal Company
Indications and usage
INDICATIONS AND USAGE Uribel Tabs are indicated for the treatment of symptoms of irritative voiding. Indicated for the relief of local symptoms, such as inflammation, hypermotility, and pain, which accompany lower urinary tract infections. Indicated for the relief of urinary tract symptoms caused by diagnostic procedures.
Dosage and administration
DOSAGE AND ADMINISTRATION Adults One tablet orally 4 times per day followed by liberal fluid intake. Older Children Dosage must be individualized by physician. Not recommended for use in children six years of age or younger.
Warnings
WARNINGS Do not exceed recommended dosage. If rapid pulse, dizziness or blurring of vision occurs, discontinue use immediately.
Contraindications
CONTRADICTIONS Hypersensitivity to any of the ingredients is possible. Risk benefits should be carefully considered when the following medical problems exist: cardiac disease (especially cardiac arrhythmias, congestive heart failure, coronary heart disease, and mitral stenosis); gastrointestinal tract obstructive disease; glaucoma; myasthenia gravis, acute urinary retention may be precipitated in obstructive uropathy (such as bladder neck obstruction due to prostatic hypertrophy).
KR · 한국Products in Korea (23)
- 투진액(목근피틴크)(주)경인제약
- 투진액(목근피틴크)1병(주)경인제약
- 히노민정(황산히오스시아민)(주)드림파마
- 히노민정(황산히오스시아민)(주)드림파마
- 살프메칠렌블루주사1%(주)삼오제약
- 살프메칠렌블루주사1%(주)삼오제약
- 살프메칠렌블루주사1%(주)삼오제약
- 살프메칠렌블루주사1%(주)삼오제약
- 엔터팜메칠렌블루주사1%(주)엔터팜
- 치선액(주)퍼슨
- 치선액(주)퍼슨
- 무조메액(주)퍼슨
- 무조메액(주)퍼슨
- 무조메액(주)퍼슨
- 디비팜메칠렌블루주사1%(주)한국디비팜
- 치선액미쓰비시다나베파마코리아 주식회사
- 치선액미쓰비시다나베파마코리아 주식회사
- 목근액월드원트레이드
- 목근액월드원트레이드
- 바라돈정(황산히요스시아민)위더스제약(주)
View more: Full FDA label on DailyMed →Label effective 20260108